Literature DB >> 18349542

Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002.

A B Kimball1, D Robinson, Y Wu, C Guzzo, N Yeilding, C Paramore, K Fraeman, M Bala.   

Abstract

BACKGROUND: Cardiovascular diseases or risk factors (CVDR) seem to be more common in psoriasis patients than in the general population.
OBJECTIVE: We assessed the relationship of psoriasis with CVDR by analysis of healthcare claims data using a cross-sectional, prevalence-based study design. PATIENTS AND METHODS: The IMS Health and MarketScan claims databases were used to identify adults with psoriasis diagnostic codes. Non-psoriasis controls were matched 3:1 based on age, gender, census region and previous medical insurance coverage. Odds ratios evaluated the relative prevalence of CVDR, and Mantel-Haenszel confidence intervals were estimated.
RESULTS: CVDR prevalence was generally higher in psoriasis patients than controls in both datasets. Odds ratios for atherosclerosis, congestive heart failure, type 2 diabetes, and peripheral vascular disease were >or=1.20 for psoriasis patients. Elevated disease severity was associated with a higher rate of CVDR, but varied somewhat by dataset and condition.
CONCLUSIONS: Elevated CVDR rates were found in psoriasis patients compared with controls. This pattern merits further examination. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18349542     DOI: 10.1159/000121333

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  37 in total

1.  Validity of The Health Improvement Network (THIN) for the study of psoriasis.

Authors:  N M Seminara; K Abuabara; D B Shin; S M Langan; S E Kimmel; D Margolis; A B Troxel; J M Gelfand
Journal:  Br J Dermatol       Date:  2011-02-03       Impact factor: 9.302

2.  Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts.

Authors:  Majed Khraishi; Don MacDonald; Emmanouil Rampakakis; Julie Vaillancourt; John S Sampalis
Journal:  Clin Rheumatol       Date:  2011-02-02       Impact factor: 2.980

3.  Pediatric Psoriasis Comorbidity Screening Guidelines.

Authors:  Emily Osier; Audrey S Wang; Megha M Tollefson; Kelly M Cordoro; Stephen R Daniels; Andrew Eichenfield; Joel M Gelfand; Alice B Gottlieb; Alexa B Kimball; Mark Lebwohl; Nehal N Mehta; Amy S Paller; Jeffrey B Schwimmer; Dennis M Styne; Abby S Van Voorhees; Wynnis L Tom; Lawrence F Eichenfield
Journal:  JAMA Dermatol       Date:  2017-07-01       Impact factor: 10.282

4.  Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo.

Authors:  Hoyong Lim; Young Uk Kim; Hua Sun; Joyce H Lee; Joseph M Reynolds; Shino Hanabuchi; Huaizhu Wu; Ba-Bie Teng; Yeonseok Chung
Journal:  Immunity       Date:  2014-01-09       Impact factor: 31.745

Review 5.  Chronic inflammatory diseases, myocardial function and cardioprotection.

Authors:  Antigone Lazou; Ignatios Ikonomidis; Monika Bartekova; Theodora Benedek; George Makavos; Dimitra Palioura; Hector Cabrera Fuentes; Ioanna Andreadou
Journal:  Br J Pharmacol       Date:  2020-02-08       Impact factor: 8.739

6.  Risk and predictors of cardiovascular disease in psoriasis: a population-based study.

Authors:  Hilal Maradit-Kremers; Ross A Dierkhising; Cynthia S Crowson; Murat Icen; Floranne C Ernste; Marian T McEvoy
Journal:  Int J Dermatol       Date:  2013-01       Impact factor: 2.736

7.  Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis.

Authors:  Rahat S Azfar; Nicole M Seminara; Daniel B Shin; Andrea B Troxel; David J Margolis; Joel M Gelfand
Journal:  Arch Dermatol       Date:  2012-09

Review 8.  Relationship between tumor necrosis factor-α inhibitors and cardiovascular disease in psoriasis: a review.

Authors:  Thao Nguyen; Jashin J Wu
Journal:  Perm J       Date:  2014

Review 9.  Management of cardiovascular disease risk in chronic inflammatory disorders.

Authors:  Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2009-04       Impact factor: 20.543

10.  Biological depletion of neutrophils attenuates pro-inflammatory markers and the development of the psoriatic phenotype in a murine model of psoriasis.

Authors:  George Han; Annika Havnaer; Hiu Ham Lee; Dylan J Carmichael; Luis R Martinez
Journal:  Clin Immunol       Date:  2019-10-31       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.